Market Research Logo

Biologics Global Market Outlook 2018Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline

Biologics Global Market Outlook 2018Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Sanofi

North America was the largest region in the biologics market in 2017, accounting for around 40% market share. This can be attributed to the high per capita healthcare expenditure in the region and the investment in novel treatments leading to the early adoption of new anti-inflammatory, anti-cancer and anti-viral biologics in the region. Western Europe was the second largest region accounting for around 23% market share. Asia Pacific was the third largest region accounting for around 16% market share.

Biologics Global Market Outlook 2018 provides strategists, marketers and senior management with the critical information they need to assess the global biologics sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Biologics Global Market Outlook 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the biologics market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the biologics market and suggests approaches.

Scope

Markets Covered: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.

Companies Mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Novo Nordisk

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Biologics Market Characteristics
Biologics Market Historic Growth (2013-17)
Biologics Market Forecast Growth (2017-21)
Biologics Market Segmentation
Global Biologics Market, Split By Segments, 2017, $ Billion
Monoclonal Antibodies (MAbS)
Therapeutic Proteins
Vaccines
Global Biologics Market, Historic and Forecast, Split By Segments, 2013-2021
Biologics Market Geography Regional and Country Comparison
Global Biologics Market, Split By Regions, 2017
Global Biologics Market, Historic And Forecast Growth (2017-21) Rate, Split By Region, 2013-2021
Global Biologics Market, Split By Country, 2017
Global Biologics Market, Historic And Forecast Growth (2017-21) Rate, Split By Country, 2013-2021
Biologics Market Competitive Landscape
Amgen
AbbVie Inc.
Johnson & Johnson
Bristol-Myers Squibb Company
Pfizer Inc.
Eli Lilly And Company
F. Hoffmann-La Roche Ltd.
Merck & Co.
GlaxosmithKline Plc.
Sanofi S.A.
Amgen
AbbVie
Johnson & Johnson (J&J)
Biologics Market Key Mergers And Acquisitions
ADMA Biologics Acquired Biotest’s Therapy Business
Pfizer Acquired Baxter’s Vaccine Portfolio
GlaxoSmithKline Acquired Okairos AG
CSL Acquired Novartis’ Vaccine Business
Serum Institute Acquired Nanotherapeutics Inc.
Eagle Pharmaceuticals Acquired Arsia Therapeutics
Takeda Acquired Baxalta’s Manufacturing Facility
Biologics Market Trends And Strategies
Demand For Biologics In The Treatment Of Complex Diseases
Increasing Demand For Antibody Drug Conjugates (ADCs)
Development Of Next Generation Biologics
Revised FDA Approvals To Facilitate Biologics Drug Development
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report